Compounds > s 9788
Page last updated: 2024-09-02

s 9788 and Leukemia P388

s 9788 has been researched along with Leukemia P388 in 5 studies

*Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. [MeSH]

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atassi, G; Dhainaut, A; Kraus-Berthier, L; Léonce, S; Pierré, A; Prost, JF; Régnier, G1
Atassi, G; Dhainaut, A; Guilbaud, N; Kraus-Berthier, L; Leonce, S; Pierre, A; Regnier, G; Tizot, A1
Anstett, M; Atassi, G; Bizzari, JP; Genton, A; Léonce, S; Pérez, V; Pierré, A1
Atassi, G; Berlion, M; Bizzari, JP; Cros, S; Dhainaut, A; Dunn, T; Guilbaud, N; Regnier, G1
Atassi, G; Berlion, M; Bizzari, JP; Dhainaut, A; Dunn, TA; Kraus-Berthier, L; Léonce, S; Pierré, A; Régnier, G; Saint-Dizier, D1

Other Studies

5 other study(ies) available for s 9788 and Leukemia P388

ArticleYear
New triazine derivatives as potent modulators of multidrug resistance.
    Journal of medicinal chemistry, 1992, Jun-26, Volume: 35, Issue:13

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cell Survival; Cricetinae; Cricetulus; Drug Resistance; Drug Synergism; Leukemia P388; Lung; Membrane Glycoproteins; Structure-Activity Relationship; Triazines; Tumor Cells, Cultured

1992
New purines and purine analogs as modulators of multidrug resistance.
    Journal of medicinal chemistry, 1996, Sep-27, Volume: 39, Issue:20

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channels; Doxorubicin; Drug Resistance, Multiple; Female; Leukemia P388; Leukemia, Experimental; Mice; Molecular Structure; Neoplasm Transplantation; Piperidines; Purines; Structure-Activity Relationship; Triazines; Tumor Cells, Cultured; Vincristine

1996
Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Biochemical pharmacology, 1992, Nov-03, Volume: 44, Issue:9

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Carcinoma, Squamous Cell; Cell Cycle; Cell Membrane; Cells, Cultured; Colonic Neoplasms; Cricetinae; Cricetulus; Dihydropyridines; Doxorubicin; Drug Resistance; Flow Cytometry; Fluorescence; Humans; Kinetics; Leukemia P388; Leukemia, Myeloid, Acute; Lung; Membrane Glycoproteins; Mice; Piperidines; Sensitivity and Specificity; Triazines; Tritium; Tumor Cells, Cultured; Verapamil

1992
In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Resistance; Female; Leukemia P388; Mice; Mice, Inbred Strains; Piperidines; Triazines; Vincristine

1992
In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative.
    Investigational new drugs, 1992, Volume: 10, Issue:3

    Topics: Animals; Antineoplastic Agents; Cell Line; Doxorubicin; Drug Interactions; Flow Cytometry; Humans; Leukemia P388; Mice; Piperidines; Triazines; Vincristine

1992